Position in BIO
as of Mar 31, 2026
· filed Apr 28, 2026
Position Value
$1,672
-$299 QoQ
Shares Held
6
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BIO Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Raleigh Capital Management Inc. holds $2,808,607 across 7 Medical Devices names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MDT |
Medtronic plc
|
30,084 | $2,353,471 | |
| 2 | BSX |
Boston Scientific Corp
|
5,395 | $230,258 | |
| 3 | ABT |
Abbott Laboratories
|
1,942 | $176,217 | |
| 4 | SYK |
Stryker Corp
|
117 | $36,836 | |
| 5 | STE |
STERIS plc
|
48 | $10,107 | |
| 6 | EW |
Edwards Lifesciences Corp
|
19 | $1,718 | |
| 7 | ZBH |
Zimmer Biomet Holdings, Inc.
|
0 | $0 |
All Filings in BIO
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,672 | 6 | Shares | Sole | 2026-04-28 | |
| 2024-12-31 | $1,971 | 6 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $4,014 | 12 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $1,911 | 7 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $1,037 | 3 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $322 | 1 | Shares | Sole | 2024-02-21 | |
| 2023-03-31 | $38,800 | 81 | Shares | Sole | 2023-05-22 | |
| 2022-12-31 | $14,296 | 34 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $5,005 | 12 | Shares | Sole | 2022-11-09 | |
| No filing history on record for this holder in this stock. | ||||||